Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04163081
Other study ID # 20190485-01H
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date April 19, 2022
Est. completion date November 2026

Study information

Verified date January 2024
Source Ottawa Heart Institute Research Corporation
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The INITIATE Study is a randomized controlled trial that is testing an intervention designed to increase long-term abstinence among tobacco smokers seen in emergency departments (ED). The intervention includes a behavioural incentive and tailored follow-up support on long-term smoking abstinence, health, healthcare utilization, and cost. Tobacco-related illnesses cost the healthcare system millions each year. Quitting smoking improves smoking-related outcomes, like the onset or management of heart disease, stroke, lung diseases, and several cancers. There are approximately 16 million visits to Canadian EDs each year; an estimated 3-4 million of these involve smokers. Effective quit smoking interventions exist, but are underutilized. Few hospital EDs in Canada offer tobacco-use interventions. In order for ED staff to offer quit smoking support, interventions need to be simple given the realities of the ED environment. Considering that stopping smoking improves health outcomes, that tobacco-use is an important cause of preventable ED use, and the volume of smokers, Canadian EDs are a missed opportunity in the initiation of quit smoking support. Our intervention has been designed to optimize uptake and smoking abstinence by including the most effective evidence-based behavioural and drug-related approaches, removing specific barriers and challenges that smokers face when trying to quit (e.g., affordability, low confidence and motivation), while packaging the intervention in a quick-to-initiate manner, making it ideal for fast-paced, complex ED environments.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 1208
Est. completion date November 2026
Est. primary completion date August 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Current daily smoker (smokes = 5 cigarettes per day); - = 18 years of age (the age of majority in Ontario); - Assigned a CTAS level of 2-5 (emergent to non-urgent); - Able to read and understand English or French; - Resides in Ontario and eligible for Ontario Health Insurance Plan (to permit linkage with administrative data housed at the Institute for Clinical Evaluative Sciences [ICES]); - Available and willing to participate in follow-up assessments over the next 24 months; - Has access to a telephone or computer; - Able to provide informed consent Exclusion Criteria: - Currently participating in this or another smoking cessation study; - Assigned a CTAS level of 1 (resuscitation - the most seriously ill patients with highest likelihood of hospital admission) or in psychiatric emergency unit; - Pregnant, planning to become pregnant over the next 2 years, or breastfeeding; - Has morbid illness which will prevent completion of 26-week follow-up (e.g., receiving palliative care); - In the opinion of the ED physician, manifests acute physical and/or psychiatric illness or has cognitive impairment that would preclude participation in/benefit from the intervention.

Study Design


Intervention

Behavioral:
Quit Card Intervention (QCI)
The intervention is comprised of a behavioural incentive in the form of a gift card as well as tailored smoking cessation counseling. Eligible consenting smokers randomized to the QCI group will receive: a "Quit Card" (a gift card worth $300 that can be used to buy nicotine replacement therapies at any pharmacy); self-help information; and, enrollment in six months of telephone follow-up support tailored by treatment goal with a Nicotine Addiction Treatment Specialist.

Locations

Country Name City State
Canada The Ottawa Hospital Civic Campus Ottawa Ontario
Canada The Ottawa Hospital General Campus Ottawa Ontario

Sponsors (2)

Lead Sponsor Collaborator
Ottawa Heart Institute Research Corporation Canadian Institutes of Health Research (CIHR)

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Smoking Abstinence Smoking abstinence at 26 weeks, biochemically verified using an expired air carbon monoxide (CO) test 26 weeks (6 months) after study enrollment
Secondary Prolonged Abstinence Prolonged (since last time point) smoking abstinence, at 4, 26, 52 and 104 weeks 4, 26, 52 and 104 weeks after study enrollment
Secondary Point Prevalence Abstinence Point prevalence smoking abstinence, at 4, 52 and 104 weeks 4, 52 and 104 weeks after study enrollment
Secondary Smoking Reduction Smoking reduction (i.e., change in number of daily cigarettes), at 4, 26, 52 and 104 weeks 4, 26, 52 and 104 weeks after study enrollment
Secondary Number of Quit Attempts Number of quit attempts since study entry, at 4, 26, 52 and 104 weeks 4, 26, 52 and 104 weeks after study enrollment
Secondary Cessation Medication and/or E-cigarette Use Use of smoking cessation medication and/or e-cigarette, at 4, 26, 52 and 104 weeks 4, 26, 52 and 104 weeks after study enrollment
Secondary Use of Behavioural Supports Use of behavioural supports (e.g., counseling, quit lines), at 4, 26, 52 and 104 weeks 4, 26, 52 and 104 weeks after study enrollment
Secondary Health-Related Quality of Life Health-related quality of life (HR-QoL), at 52 and 104 weeks. This will be measured using the 36-Item Short Form Health Survey (SF-36), where each item is scored so that the lowest and highest possible scores are 0 and 100 respectively, and a high score outlines a more favorable state of health. 52 and 104 weeks after study enrollment
Secondary Health Services Outcomes - ED visits Number of all-cause and smoking-related (e.g., vascular, respiratory, cancer-related) visits to ED at 4, 26, 52 and 104 weeks 4, 26, 52 and 104 weeks after study enrollment
Secondary Health Services Outcomes - Hospital Admissions Number of all-cause and smoking-related (e.g., vascular, respiratory, cancer-related) admissions to hospital at 4, 26, 52 and 104 weeks 4, 26, 52 and 104 weeks after study enrollment
Secondary Health Services Outcomes - Deaths Number of all-cause and smoking-related (e.g., vascular, respiratory, cancer-related) deaths at 4, 26, 52 and 104 weeks 4, 26, 52 and 104 weeks after study enrollment
Secondary Cost-Effectiveness Ratios Cost-effectiveness ratios related to health services at 52 and 104 weeks 52 and 104 weeks after study enrollment
See also
  Status Clinical Trial Phase
Completed NCT05477342 - Reducing Nicotine Addiction in Adolescent Smokers N/A
Completed NCT03011710 - Epidemiology and Acute Oral Effects Electronic Cigarette N/A
Recruiting NCT03194919 - Negotiating a Quit Date or Not in Online Interventions N/A
Recruiting NCT03191825 - Online Lapse Management Intervention N/A
Completed NCT03719391 - United States Pre-Market Tobacco Application Pharmacokinetics N/A
Completed NCT05538702 - Acute Oral Effects of Heated Tobacco Products N/A
Completed NCT02723162 - Translational Neuropsychopharmacology Research of Nicotine Addiction Phase 2
Completed NCT03194958 - Helping Poor Smokers Quit N/A
Completed NCT03593239 - Comparing the Pharmacokinetics of Nicotine Salt Based ENDS in Healthy Smokers N/A
Completed NCT04830384 - Evaluation of LLLT/Music for Smoking Cessation N/A
Completed NCT02367391 - Penn State TXT2Quit Study N/A
Recruiting NCT05665465 - Neurobehavioral Mechanisms Linking Childhood Adversity to Increased Risk for Smoking Early Phase 1
Completed NCT04805515 - Impact of Nicotine Messaging on Nicotine Beliefs and Tobacco Use Behavior N/A
Completed NCT03700112 - Clinical Study Comparing 7 ENDS Products and 1 Combustible Cigarette Using 2 Delivery Methods. N/A
Terminated NCT02986711 - Penn State TXT2STAYQUIT Study- a Texting Study to Help Hospitalized Smokers Stay Quit N/A
Recruiting NCT05224154 - Re-Connect Application for Smoking Cessation N/A
Completed NCT03492463 - The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion Products Phase 2
Withdrawn NCT03473483 - Cigarette Harm Reduction With Electronic Cigarette Use N/A
Completed NCT04379388 - Improving Smoking Cessation in Socioeconomically-Disadvantaged Young Adults N/A